Samarth Kulkarni - Net Worth and Insider Trading

Over the past 18 months, Samarth Kulkarni made 14 insider transaction in CRISPR Therapeutics AG (CRSP) with a net sale of 261,024. Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 25,642 shares made by James R. Kasinger , a net sale of 6,801 shares made by , and a net sale of 9,483 shares made by Raju Prasad .

In summary, during the past 3 months, insiders sold 89,481 shares of CRISPR Therapeutics AG (CRSP) in total and bought 7,000 shares, with a net sale of 82,481 shares. During the past 18 months, 302,950 shares of CRISPR Therapeutics AG (CRSP) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 295,950 shares.

CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Samarth Kulkarni made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 34,270 shares made by Lloyd Mitchell Segal , a net sale of 10,973 shares made by Steve Forte , and a net sale of 7,821 shares made by Michael Zinda .

In summary, during the past 3 months, insiders sold 37,270 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 37,270 shares. During the past 18 months, 58,960 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,952,050 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Samarth Kulkarni made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net sale of 5,784,292 shares made by Biotech Growth N V , and a net sale of 221,600 shares made by Versant Venture Capital Vi, L.p. .

In summary, during the past 3 months, insiders sold 5,784,292 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 5,784,292 shares. During the past 18 months, 6,005,892 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,005,892 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Samarth Kulkarni made no insider transaction in Centessa Pharmaceuticals PLC (CNTA). Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 795,000 shares made by Saurabh Saha , a net sale of 178,339 shares made by Gregory M Weinhoff , and a net sale of 105,086 shares made by Karen M. Anderson .

In summary, during the past 3 months, insiders sold 277,404 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 277,404 shares. During the past 18 months, 1,223,821 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,223,821 shares.

Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.